[1] J. Ye et al., “Searching for the definition of macrosomia through an outcome-based approach in low- and middle-income countries: A secondary analysis of the WHO Global Survey in Africa, Asia and Latin America,” BMC Pregnancy Childbirth, vol. 15, no. 1, pp. 1–10, 2015, doi: 10.1186/s12884-015-0765-z.
[2] M. C. Dennedy and F. Dunne, “Macrosomia: Defining the problem worldwide,” Lancet, vol. 381, no. 9865, pp. 435–436, 2013, doi: 10.1016/S0140-6736(12)62090-X.
[3] ACOG, “Clinical Management Guidelines for Obstetrician – Gynecologists,” Obstet. Gynecol., vol. 133, no. 76, pp. 168–186, 2019.
[4] L. J. Black MH, Sacks DA, Xiang AH, “The relative contribution of prepregnancy overweight and obe- sity, gestational weight gain, and IADPSG-defined gesta- tional diabetes mellitus to fetal overgrowth,” Diabetes Care, vol. 36, pp. 56–62, 2013, doi: 10.2337/dc12-0741.
[5] C. A. Asplund, “1543-1410-1-SM.pdf,” pp. 550–554, 2008, doi: 10.1370/afm.903.INTRODUCTION.
[6] G. Pagani, N. Palai, S. Zatti, N. Fratelli, F. Prefumo, and T. Frusca, “Fetal weight estimation in gestational diabetic pregnancies: Comparison between conventional and three-dimensional fractional thigh volume methods using gestation-adjusted projection,” Ultrasound Obstet. Gynecol., vol. 43, no. 1, pp. 72–76, 2014, doi: 10.1002/uog.12458.
[7] A. S. Said and K. P. Manji, “Risk factors and outcomes of fetal macrosomia in a tertiary centre in Tanzania: A case-control study,” BMC Pregnancy Childbirth, vol. 16, no. 1, pp. 1–8, 2016, doi: 10.1186/s12884-016-1044-3.
[8] R. N. Akindele, L. I. Audu, and O. A. Mokuolu, “Macrosomic births in Abuja: A case-control study of predisposing factors and early neonatal outcome,” Niger. J. Clin. Pract., vol. 20, no. 3, pp. 320–327, 2017, doi: 10.4103/1119-3077.196060.
[9] K. Bedu-Addo et al., “Prevalence and associated factors of fetal macrosomia in a rural community in Ghana,” Cogent Med., vol. 7, no. 1, 2020, doi: 10.1080/2331205x.2020.1746602.
[10] M. Thorsell, M. Kaijser, H. Almström, and E. Andolf, “Large fetal size in early pregnancy associated with macrosomia,” Ultrasound Obstet. Gynecol., vol. 35, no. 4, pp. 390–394, 2010, doi: 10.1002/uog.7529.
[11] R. Cunningham FG, Levenok K, Cunningham FG, Levenok K, Rouse, Macrosomia. In: Williams Obstretrics. 24rd edition. McGraw Hill; 2013. p. 1325–40. McGraw Hill, 2013.
[12] V. L. Bandika, F. N. Were, E. D. Simiyu, and D. P. Oyatsi, “Hypoglycaemia and hypocalcaemia as determinants of admission birth weight criteria for term stable low risk macrosomic neonates,” Afr. Health Sci., vol. 14, no. 3, pp. 510–516, 2014, doi: 10.4314/ahs.v14i3.3.
[13] M. H. K. Maher, R. Soltani, A. H. Zeinalzadeh, and S. Pourasghar, “Complications and risk factors of neonatal macrosomia: A case-control study,” Iran. J. Neonatol., 2018.
[14] C. Kadji, M. M. Cannie, S. Resta, and D. Guez, “Expert Review Magnetic resonance imaging for prenatal estimation of birthweight in pregnancy : review of available data , techniques , and future perspectives,” Am. J. Obstet. Gynecol., 2019, doi: 10.1016/j.ajog.2018.12.031.
[15] G. L. Malin, G. J. Bugg, Y. Takwoingi, and J. G. Thornton, “Antenatal magnetic resonance imaging versus ultrasound for predicting neonatal macrosomia : a systematic review and meta-analysis,” no. March, pp. 77–88, 2016, doi: 10.1111/1471-0528.13517.
[16] WHO/IDF, “definition and diagnosis of diabetes mellitus and intermediate hyperglycemia RepoRt of a WHo/IDf ConsultatIon,” 2006.
[17] M. A. Alsammani and S. R. Ahmed, “Fetal and maternal outcomes in pregnancies complicated with fetal macrosomia,” N. Am. J. Med. Sci., vol. 4, no. 6, pp. 283–286, 2012, doi: 10.4103/1947-2714.97212.
[18] F. G. Tela, A. M. Bezabih, A. K. Adhanu, and K. B. Tekola, “Fetal macrosomia and its associated factors among singleton live-births in private clinics in Mekelle city, Tigray, Ethiopia,” BMC Pregnancy Childbirth, vol. 19, no. 1, pp. 1–6, 2019, doi: 10.1186/s12884-019-2379-3.
[19] T. H. Hung and T. T. an. Hsieh, “Pregestational body mass index, gestational weight gain, and risks for adverse pregnancy outcomes among Taiwanese women: A retrospective cohort study,” Taiwan. J. Obstet. Gynecol., vol. 55, no. 4, pp. 575–581, 2016, doi: 10.1016/j.tjog.2016.06.016.
[20] H. Soltani, N. I. Lipoeto, F. J. Fair, K. Kilner, and Y. Yusrawati, “Pre-pregnancy body mass index and gestational weight gain and their effects on pregnancy and birth outcomes: A cohort study in West Sumatra, Indonesia,” BMC Womens. Health, vol. 17, no. 1, pp. 1–12, 2017, doi: 10.1186/s12905-017-0455-2.
[21] T. Pongcharoen, S. Gowachirapant, P. Wecharak, N. Sangket, and P. Winichagoon, “Pre-pregnancy body mass index and gestational weight gain in Thai pregnant women as risks for low birth weight and macrosomia,” Asia Pac. J. Clin. Nutr., 2016, doi: 10.6133/apjcn.092015.41.
[22] M. H. Vickers, “Developmental programming and transgenerational transmission of obesity,” Ann. Nutr. Metab., vol. 64, no. SUPPL.1, pp. 26–34, 2014, doi: 10.1159/000360506.
[23] H. Yadav and N. Lee, “Factors influencing macrosomia in pregnant women in a tertiary care hospital in Malaysia,” J. Obstet. Gynaecol. Res., vol. 40, no. 2, pp. 439–444, 2014, doi: 10.1111/jog.12209.
[24] A. W. Mwanri, Gestational diabetes mellitus in Tanzania - public health perspectives. 2015.
[25] E. Nkwabong and G. R. Nzalli Tangho, “Risk Factors for Macrosomia,” J. Obstet. Gynecol. India, vol. 65, no. 4, pp. 226–229, 2015, doi: 10.1007/s13224-014-0586-4.
[26] M. Mongelli, R. Benzie, and G. Condous, “Average fetal weekly weight gain: A novel measure of fetal growth velocity,” J. Matern. Neonatal Med., vol. 29, no. 4, pp. 676–679, 2016, doi: 10.3109/14767058.2015.1015981.
[27] G. Bray Madoue, S. Nguele Sile, F. Lhagadang, and A. Saleh, “Foetal macrosomia: risk factors, maternal and foetal outcome in N’Djamena mother and child hospital, Chad,” Obstet. Gynecol. Int. J., vol. 9, no. 3, pp. 40–43, 2018, doi: 10.15406/ogij.2018.09.00322.
[28] A. K. Biratu, N. Wakgari, and B. Jikamo, “Magnitude of fetal macrosomia and its associated factors at public health institutions of Hawassa city, southern Ethiopia,” BMC Res. Notes, vol. 11, no. 1, pp. 1–6, 2018, doi: 10.1186/s13104-018-4005-2.
[29] W. Ricart et al., “Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses,” J. Epidemiol. Community Health, vol. 63, no. 1, pp. 64–68, 2009, doi: 10.1136/jech.2008.074542.